2.27
0.44%
0.01
After Hours:
2.30
0.03
+1.32%
Acumen Pharmaceuticals Inc Stock (ABOS) Financials Data
Income Statement
Quarterly
*All numbers in millions
Period End Date | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Period Length | 3 Months | 3 Months | 3 Months | 3 Months | 3 Months |
Revenues |
-
|
- | - | - | - |
Operating Expenses
|
3.85%
17.77
|
18.49 | 16.04 | 13.48 | 13.13 |
Interest Income/Expense |
1.00
|
- | - | - | - |
Operating Income/Loss |
3.85%
-17.77
|
-18.49 | -16.04 | -13.48 | -13.13 |
Nonoperating Income/Loss |
45.85%
2.901
|
1.989 | 3.082 | 1.868 | 1.828 |
Income/Loss From Continuing Operations Before Tax |
9.84%
-14.87
|
-16.50 | -12.96 | -11.61 | -11.31 |
Income/Loss From Continuing Operations After Tax |
9.84%
-14.87
|
-16.50 | -12.96 | -11.61 | -11.31 |
Net Income/Loss
|
9.84%
-14.87
|
-16.50 | -12.96 | -11.61 | -11.31 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
1,808%
59.81
|
3.1344 | 54.23 | 41.03 | 41.03 |
Diluted Average Shares |
1,808%
59.81
|
3.1344 | 54.23 | 41.03 | 41.03 |
Basic Earnings Per Share |
13.79%
-0.25
|
-0.29 | -0.24 | -0.28 | -0.28 |
Diluted Earnings Per Share |
13.79%
-0.25
|
-0.29 | -0.24 | -0.28 | -0.28 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):